Silo Pharma, Inc.
SILO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,393 | -$3,701 | -$3,909 | $4,157 |
| Dep. & Amort. | $6 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $14 | $156 | $0 |
| Change in WC | $552 | $299 | -$75 | $705 |
| Other Non-Cash | $1 | $163 | $330 | -$7,140 |
| Operating Cash Flow | -$3,834 | -$3,224 | -$3,498 | -$2,278 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$176 | -$4,147 | $0 | $0 |
| Inv. Sales/Matur. | $1,149 | $0 | $67 | $7,021 |
| Other Inv. Act. | $0 | $0 | $20 | $172 |
| Investing Cash Flow | $974 | -$4,147 | $87 | $7,193 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,415 | $0 | $4,941 | $3,794 |
| Stock Repurch. | -$173 | -$471 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $3,242 | -$471 | $4,941 | $3,794 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $381 | -$7,843 | $1,530 | $8,709 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,524 | $11,367 | $9,837 | $1,128 |
| End Cash | $3,906 | $3,524 | $11,367 | $9,837 |
| Free Cash Flow | -$3,834 | -$3,224 | -$3,498 | -$2,278 |